P M Sweetnam

Medicine · Health Sciences

50h-index15.2kcitations119works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Diabetes, Cardiovascular Risks, and Lipoproteins(22), Blood properties and coagulation(22), Adipokines, Inflammation, and Metabolic Diseases(10), Lipoproteins and Cardiovascular Health(9), Obesity, Physical Activity, Diet(8)

Publications117 total

Leg length, insulin resistance, and coronary heart disease risk:
Bristol University Press eBooks·2017· 1 cited
Sweetnam, Peter: transcript of an audio interview (31-May-2000)
Queen Mary Research Online (Queen Mary University of London)·2017Open Access
Systematically missing confounders in individual participant data meta‐analysis of observational cohort studies
Statistics in Medicine·2009· 55 citedOpen Access
Plasma Fibrinogen Level and the Risk of Major Cardiovascular Diseases and Nonvascular Mortality
JAMA·2005· 1.1k cited
C-Reactive Protein, Fibrin D-Dimer, and Risk of Ischemic Heart Disease
Arteriosclerosis Thrombosis and Vascular Biology·2004· 64 citedOpen Access
Resonance‐thrombography indices of the haemostatic process in relation to risk of incident coronary heart disease: 9 years follow‐up in the Caerphilly Prospective Heart Disease Study
British Journal of Haematology·2004· 3 citedOpen Access
Leg length, insulin resistance, and coronary heart disease risk: the Caerphilly Study
Policy Press eBooks·2003· 1 cited
Leg length, insulin resistance, and coronary heart disease risk: the Caerphilly Study
Policy Press eBooks·2003· 6 cited
Is Type A Behavior Really a Trigger for Coronary Heart Disease Events?
Psychosomatic Medicine·2003· 57 cited
High density lipoprotein subfractions and the risk of coronary heart disease: 9-years follow-up in the Caerphilly Study
Atherosclerosis·2003· 55 cited
Lifestyle factors and coagulation activation markers: the Caerphilly Study
Blood Coagulation & Fibrinolysis·2001· 53 cited
C-reactive protein, fibrin D-dimer, and incident ischaemic heart disease: the Caerphilly and Speedwell studies
BMC News and views·2001Open Access
Do Total and High Density Lipoprotein Cholesterol and Triglycerides Act Independently in the Prediction of Ischemic Heart Disease?
Arteriosclerosis Thrombosis and Vascular Biology·2001· 64 citedOpen Access
C-Reactive Protein, Fibrin D-Dimer, and Incident Ischemic Heart Disease in the Speedwell Study
Arteriosclerosis Thrombosis and Vascular Biology·2001· 200 cited
Fibrin D-dimer, Markers of Coagulation Activation and the Risk of Major Ischaemic Heart Disease in the Caerphilly Study
Thrombosis and Haemostasis·2001· 58 cited
Apolipoproteins A–I, A–II and B, lipoprotein(a) and the risk of ischaemic heart disease: the Caerphilly Study
European Journal of Clinical Investigation·2000· 49 cited
Lifestyle and Hemostatic Risk Factors for Ischemic Heart Disease
Arteriosclerosis Thrombosis and Vascular Biology·2000· 151 citedOpen Access
Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the Caerphilly prospective heart disease study   Commentary: Chlamydia pneumoniae infection and ischaemic heart disease
BMJ·1999· 135 citedOpen Access
Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study
British Journal of Haematology·1999· 184 cited
Cytomegalovirus seropositivity and incident ischaemic heart disease in the Caerphilly prospective heart disease study
Heart·1999· 22 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

P C Elwood(33), J. W. G. Yarnell(26), D Bainton(11), Ian Baker(10), C. Bolton(7), Gordon Lowe(5), George Davey Smith(4), N.E. Miller(4), Ann Rumley(4), H F Thomas(4), A M Fehily(3), A. Rumley(3), Andrew D Beswick(3), R. D. Eastham(3), M.D. Etherington(3), S Rogers(2), A. C. Wilson(2), Uri Goldbourt(2), J W Yarnell(2), Anne Tybjærg‐Hansen(2)